Sodium Intake in Ecuadorian Population

• Sponsor: Universidad San Francisco de Quito (Other)
• Overall Status: Completed
• CT.gov ID: NCT03154502
• Collaborator: (none)
• Enrollment: 130
• Actual Duration (Months): 20

Study Details

Study Description

Brief Summary

This study is aim to determine the sodium intake in Ecuadorian population that is an unknown information at present. For that, 24h urine samples will be collected from 130 subjects working either at tue USFQ or HDLV to measure sodium excretion.

Condition or Disease	Intervention/Treatment	Phase
Dietary Habits; Risk Factor, Cardiovascular; Nutritional Disorder	Diagnostic Test: Urinary sodium excretion

Study Design

• Study Type: Observational
• Actual Enrollment: 130 participants
• Observational Model: Cohort
• Time Perspective: Cross-Sectional
• Official Title: Sodium Urinary Excretion Measurement in Ecuadorian Population
• Actual Study Start Date: Mar 1, 2015
• Actual Primary Completion Date: Oct 30, 2016
• Actual Study Completion Date: Oct 30, 2016

Outcome Measures

Primary Outcome Measures

1. Urinary sodium excretion [1 year]

   Amount of sodium in 24h urine collection

Eligibility Criteria

Criteria

• Ages Eligible for Study: 25 Years to 64 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• None

Exclusion Criteria:

• unable to provide informed consent

• unable to provide 24-hr urine excretion sample

• those with a known history of heart or kidney failure, stroke, and liver disease

• those using diuretics, multivitamins, NSADs, or prostaglandins during the last two weeks

• pregnant women

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

• Universidad San Francisco de Quito

Investigators

• Study Director: Enrique Teran, MD, PhD, Universidad San Francisco de Quito

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Ivan Sisa, Associate Professor, Universidad San Francisco de Quito
• ClinicalTrials.gov Identifier: NCT03154502
• Other Study ID Numbers: HUBI-1022
• First Posted: May 16, 2017
• Last Update Posted: May 16, 2017
• Last Verified: May 1, 2017

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Ivan Sisa, Associate Professor, Universidad San Francisco de Quito: Sodium intake; Urinary sodium excretion
• Additional relevant MeSH terms: Nutrition Disorders

Study Results

No Results Posted as of May 16, 2017